Clazakizumab® (anti-il-6) Desensitization in Highly-HLA Sensitized Patients Awaiting Kidney Transplant (nct03380962): Long-Term Follow Up.

被引:0
|
作者
Vo, A. [1 ]
Tang, J. [1 ]
Ammerman, N. [1 ]
Huang, E. [1 ]
Zhang, X. [2 ]
Haas, M. [3 ]
Peng, A. [1 ]
Najjar, R. [1 ]
Williamson, S. [1 ]
Meyers, C. [1 ]
Sethi, S. [1 ]
Lim, K. [1 ]
Gillespie, M. [1 ]
Badash, N. [1 ]
Jordan, S. [1 ]
机构
[1] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, HLA Lab, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Pathol, Los Angeles, CA 90048 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
401
引用
收藏
页码:508 / 508
页数:1
相关论文
共 21 条
  • [1] CLAZAKIZUMAB® (ANTI-IL-6) FOR DESENSITIZATION OF HIGHLY-HLA SENSITIZED PATIENTS AWAITING KIDNEY TRANSPLANT (NCT03380962)
    Vo, Ashley
    Ammerman, Noriko
    Huang, Edmund
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Najjar, Reiad
    Williamson, Summer
    Myers, Catherine
    Sethi, Supreet
    Lim, Kathlyn
    Choi, Jua
    Jordan, Stanley
    [J]. TRANSPLANTATION, 2020, 104 (09) : S104 - S105
  • [2] Desensitization Using Clazakizumab® (anti-il-6) in Highly-hla Sensitized Patients Awaiting Kidney Transplant (nct03380962)
    Vo, A. A.
    Ammerman, N.
    Huang, E.
    Toyoda, M.
    Ge, S.
    Peng, A.
    Najjar, R.
    Sethi, S.
    Williamson, S.
    Myers, C.
    Lim, K.
    Gillespie, M.
    Jordan, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 372 - 372
  • [3] Evaluation of the Safety and Tolerability of Clazakizumab® as a Desensitization Agent in Highly-HLA Sensitized ESRD Patients (NCT03380962): 12m Follow-Up
    Vo, A. A.
    Ammerman, N.
    Huang, E.
    Toyoda, M.
    Ge, S.
    Peng, A.
    Najjar, R.
    Williamson, S.
    Meyers, C.
    Sethi, S.
    Lim, K.
    Choi, J.
    Jordan, S. C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 432 - 432
  • [4] CLAZAKIZUMAB (ANTI-IL-6) INDUCES FOXP3+TREGS IN HIGHLY HLA SENSITIZED PATIENTS RECEIVING HLAI KIDNEY TRANSPLANTATION (NCT03380962)
    Jordan, Stanley
    Ge, Shili
    Ammerman, Nori
    Toyoda, Mieko
    Huang, Edmund
    Peng, Alice
    Najjar, Reiad
    Sethi, Supreet
    Williamson, Summer
    Myers, Kate
    Lim, Kathlyn
    Choi, Jua
    Vo, Ashley A.
    [J]. TRANSPLANTATION, 2020, 104 (09) : S105 - S105
  • [5] EVALUATION OF THE SAFETY AND TOLERABILITY OF CLAZAKIZUMABA ® (ANTI-IL-6 MONOCLONAL) FOR DESENSITIZATION IN HIGHLY-HLA SENSITIZED ESRD PATIENTS (NCT 03380962)
    Vo, Ashley
    Ammerman, Noriko
    Huang, Edmund
    Peng, Alice
    Najjar, Reiad
    Sethi, Supreet
    Williamson, Summer
    Myers, Kate
    Lim, Kathlyn
    Choi, Jua
    Jordan, Stanley
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 401 - 401
  • [6] Evaluation of the Safety and Tolerability of Clazakizumab® (AntiI-L-6 Monoclonal) as a Desensitization Agent in Highly-HLA Sensitized ESRD Patients (nct03380962).
    Vo, A. A.
    Ammerman, N.
    Huang, E.
    Peng, A.
    Najjar, R.
    Sethi, S.
    Williamsons, S.
    Myers, C.
    Lim, K.
    Choi, J.
    Jordan, S. C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 326 - 327
  • [7] Clazakizumab (Anti-IL-6) Induces Foxp3+Tregs in Highly HLA Sensitized Patients Desensitized for HLAi Transplantation (NCT03380962)
    Jordan, S. C.
    Ge, S.
    Ammerman, N.
    Toyoda, M.
    Huang, E.
    Peng, A.
    Najjar, R.
    Sethi, S.
    Williamson, S.
    Myers, C.
    Lim, K.
    Choi, J.
    Vo, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 899 - 899
  • [8] Long-Term (1,3,5,7 & 9 Year) Outcomes in Highly-HLA Sensitized Patients Receiving Desensitization.
    Peng, Alice
    Villicana, Rafael
    Vo, Ashley
    Jordan, Stanley
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 240 - 241
  • [9] Monitoring Inflammatory Cytokines in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts) Desensitized with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody) Followed by Transplantation (Tx)
    Ge, S.
    Petrosyan, A.
    Chu, M.
    Ammerman, N.
    Vo, A.
    Zhang, X.
    Jordan, S. C.
    Toyoda, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 901 - 901
  • [10] Long Term (1, 3, 5, 7, and 9 Year) Outcomes of Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting Deceased Donor (DD) Transplantation.
    Peng, Alice
    Villicana, Rafael
    Vo, Ashley
    Jordan, Stanley
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 640 - 641